Pathophysiologic differences in cerebral autoregulation after subarachnoid hemorrhage.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27164675)

Published in Neurology on April 22, 2016

Authors

Gabriela A Santos1, Nils Petersen1, Amir A Zamani1, Rose Du1, Sarah LaRose1, Andrew Monk1, Farzaneh A Sorond1, Can Ozan Tan2

Author Affiliations

1: From the Department of Neurology, Stroke Division (G.A.S., S.L., A.M., F.A.S.), Department of Radiology (A.A.Z.), and Department of Neurosurgery (R.D.), Harvard Medical School, Brigham and Women's Hospital; Cerebrovascular Research Laboratory and Department of Physical Medicine and Rehabilitation (C.O.T.), Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, MA; and Division of Neurocritical Care and Emergency Neurology (N.P.), Yale School of Medicine and Yale-New Haven Hospital, New Haven, CT.
2: From the Department of Neurology, Stroke Division (G.A.S., S.L., A.M., F.A.S.), Department of Radiology (A.A.Z.), and Department of Neurosurgery (R.D.), Harvard Medical School, Brigham and Women's Hospital; Cerebrovascular Research Laboratory and Department of Physical Medicine and Rehabilitation (C.O.T.), Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, MA; and Division of Neurocritical Care and Emergency Neurology (N.P.), Yale School of Medicine and Yale-New Haven Hospital, New Haven, CT. cotan@mgh.harvard.edu.

Articles cited by this

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke (2009) 5.86

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke (2012) 5.13

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08

Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke (2010) 2.99

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke (2008) 2.90

Relative contributions of sympathetic, cholinergic, and myogenic mechanisms to cerebral autoregulation. Stroke (2014) 2.09

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke (2004) 1.88

Cervical sympathetic block to reverse delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage. Stroke (2003) 1.61

Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology (2009) 1.61

Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke (1988) 1.52

The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2014) 1.52

Defining the characteristic relationship between arterial pressure and cerebral flow. J Appl Physiol (1985) (2012) 1.51

The role of myogenic mechanisms in human cerebrovascular regulation. J Physiol (2013) 1.25

Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus (2006) 1.19

The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2013) 1.18

Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage. Stroke (2012) 1.16

Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: the phase relationship between arterial blood pressure and cerebral blood flow velocity. Crit Care Med (2001) 1.15

Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage. J Cereb Blood Flow Metab (2013) 1.05

Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke (2012) 0.99

Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage. Neuroradiology (2007) 0.98

Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery (2009) 0.95

Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus. Brain Res Bull (2002) 0.90

Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. Stroke (2014) 0.87

Early perfusion computerized tomography imaging as a radiographic surrogate for delayed cerebral ischemia and functional outcome after subarachnoid hemorrhage. Stroke (2013) 0.86

Alterations of mechanical properties in canine basilar arteries after subarachnoid hemorrhage. J Neurosurg (1989) 0.85

The relationship between delayed infarcts and angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery (2013) 0.84

Cholinergic dysfunction in cognitive impairments after aneurysmal subarachnoid hemorrhage. Neurosurgery (2002) 0.83

Dynamic Autoregulatory Response After Aneurysmal Subarachnoid Hemorrhage and Its Relation to Angiographic Vasospasm and Clinical Outcome. Neurocrit Care (2015) 0.82

Dynamics of cerebral blood flow autoregulation in hypertensive patients. J Neurol Sci (2002) 0.81

Magnetic Resonance Imaging versus Computed Tomography in Transient Ischemic Attack and Minor Stroke: The More Υou See the More You Know. Cerebrovasc Dis Extra (2013) 0.81

Bilateral failure of cerebral autoregulation is related to unfavorable outcome after subarachnoid hemorrhage. Neurocrit Care (2015) 0.81

Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage: from protein kinase C to protein tyrosine kinase. Neurosurgery (2002) 0.80

Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Acta Neurochir (Wien) (2007) 0.79

Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Cerebral Blood Flow Velocities and Cerebral Autoregulation Assessment. Neurocrit Care (2015) 0.79

Constriction and dysfunction of pial arterioles after regional hemorrhage in the subarachnoid space. Brain Res (2015) 0.77